Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Six New Drugs Get EMA Nod, Radius and Portola To Fight Rejections

23 Mar 2018

• By Neena Brizmohun

3d render of Europe map Earth globe — Six new drugs received a recommendation for EU approval this month

Related Content

More Biosimilars Of Herceptin And Remicade Get EMA Yes

23 Mar 2018

Clovis Confident, Portola Not: CHMP Decides On EU Marketing Applications

20 Mar 2018

Pfizer's Mylotarg Finally Gets CHMP Nod But No New Indication For Sutent

26 Feb 2018

Related Companies

Clovis Oncology, Inc.

ViiV Healthcare

Amgen, Inc.

Novartis AG

Radius Health, Inc.

Portola Pharmaceuticals, Inc.

PharmaMar, S.A.

Ipsen SA

UCB S.A.

Vertex Pharmaceuticals Incorporated

Novartis AG

Merck & Co., Inc.

Novartis AG

Additional Topics

Europe Drug Review Approvals Regulation BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.